Answers are grounded in this paper and cite their sources.
Sir—Beltran et al. [1] recently reported an increase in the prevalence of subclinical hypothyroidism among HIV-infected patients, compared with the general population. This difference was particularly relevant for male patients. Moreover, the authors reported a statistically significant relationship between subclinical hypothyroidism, receipt of therapy containing stavudine, and the degree of immunodeficiency of the patients [1]. To assess the prevalence of subclinical hypothyroidism among HIV-infected patients and to identify the associated risk factors, we performed a retrospective analysis of HIV-infected patients who were untreated or who were receiving highly active antiretroviral therapy (HAART). The patients had been observed at 6 departments of infectious diseases and had total thyroxine and thyroid-stimulating hormone levels measured during the period of January 2000 through December 2002. Thyroid function had generally been assessed during routine testing or as part of the screening examinations performed before treatment of hepatitis C virus (HCV) coinfection and chronic hepatitis. None of these patients had any symptoms of altered thyroid function.
No takes yet. Share an insight, caveat, or question.
Quirino et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: